Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Ajalaya Teyateeti,1,2 Armeen Mahvash,3 James P Long,4 Mohamed E Abdelsalam,3 Rony Avritscher,3 Beth Chasen,1 Ahmed O Kaseb,5 Joshua D Kuban,3 Ravi Murthy,3 Bruno C Odisio,3 Achiraya Teyateeti,6 Homer A Macapinlac,1 S Cheenu Kappadath7 1Department of Nuclear Medicine, Division of Diagnostic Imaging,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Macapinlac HA, Kappadath SC
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2020-09-01
coleção:	Journal of Hepatocellular Carcinoma
Assuntos:	y90 selective internal radiation therapy therasphere prognostic factors adverse events
Acesso em linha:	https://www.dovepress.com/survival-outcomes-for-yttrium-90-transarterial-radioembolization-with--peer-reviewed-article-JHC
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!